As a medical oncologist, Kyle saw first hand the devastating effects that serious disease can have on patients and their families. This is why, after completing medical school, residency, and fellowship, he dedicated his life’s work to finding better therapies for those who desperately need them. He started by conducting research, education, and patient care as an associate professor at the University of Wisconsin. He continued his mission by leading multiple clinical research teams at AbbVie, a bio pharmaceutical company. Kyle is currently the head of development at Moderna, responsible for the clinical research programs in oncologic, rare, cardiovascular, pulmonary, and autoimmune diseases.